Literature DB >> 8384323

Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345.

T M Fong1, M A Cascieri, H Yu, A Bansal, C Swain, C D Strader.   

Abstract

Substance P is a peptide neurotransmitter that binds to the neurokinin-1 receptor and is involved in pain transmission and neurogenic inflammation. Recently, a non-peptide substance P antagonist (CP 96345) has been shown to be effective in animal models of pain and inflammation. An understanding of the molecular interactions responsible for ligand binding will be critical for the development of more specific and selective antagonists for the neurokinin-1 receptor and for the discovery of new antagonists for related G-protein-coupled receptors. Here we report that histidine at position 197 in the fifth transmembrane helix of the human neurokinin-1 receptor binds specifically to CP 96345 but not to peptide agonists. Substitution of His 197 by different amino acids and analysis of structural analogues of antagonists suggest that His 197 is involved in an amino-aromatic interaction with the benzhydryl moiety of CP 96345.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384323     DOI: 10.1038/362350a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Authors:  D C Hanson; A Nguyen; R J Mather; H Rauer; K Koch; L E Burgess; J P Rizzi; C B Donovan; M J Bruns; P C Canniff; A C Cunningham; K A Verdries; E Mena; J C Kath; G A Gutman; M D Cahalan; S Grissmer; K G Chandy
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

3.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

4.  Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.

Authors:  H Bourdon; S Trumpp-Kallmeyer; H Schreuder; J Hoflack; M Hibert; C G Wermuth
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

5.  Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors.

Authors:  J Howl; M Wheatley
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 6.  Modes of peptide binding in G protein-coupled receptors.

Authors:  M Berthold; T Bartfai
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

7.  Probing weakly polar interactions in cytochrome c.

Authors:  D S Auld; G B Young; A J Saunders; D F Doyle; S F Betz; G J Pielak
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

8.  Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.

Authors:  U Gether; Y Yokota; X Emonds-Alt; J C Brelière; J A Lowe; R M Snider; S Nakanishi; T W Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding.

Authors:  J Nardone; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

Authors:  J Culman; B Wiegand; H Spitznagel; S Klee; T Unger
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.